Key result
A review of 74 epidemiological papers on combined oral contraceptives and cardiovascular disease found only 5 papers directly addressed the clinical risk in healthy, non-smoking women under 35.
Why the study?
What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?
Population
Women aged less than 35 years, who do not smoke, and do not have a medical condition known to increase the…
Design
Review
Authors
Loading...
Most studies fail to address CVD risk in low-risk young COC users; leaves open precise estimates and requires targeted data.
What is the risk of cardiovascular disease among users of currently available, low dose, combined oral contraceptives who are aged less than 35 years, do not smoke, and do not have a medical condition known to increase the risk of vascular disease?
Most published epidemiological studies on oral contraceptives and cardiovascular risk fail to provide data in a format useful for answering specific clinical questions for low-risk patients.
Hannaford et al. (1998) conducted a review in cardiovascular disease. low dose, combined oral contraceptives was evaluated on Identification of methodologically sound studies able to address the specific clinical question. A review of 74 epidemiological papers on combined oral contraceptives and cardiovascular disease found only 5 papers directly addressed the clinical risk in healthy, non-smoking women under 35.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: